Clinical Trial Update: Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical study is evaluating UTAA91 injections for refractory rheumatoid arthritis, with the trial status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• UTAA91

Snippet

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Conditions: Rheumatoid Arthritis (RA) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING